Who is sponsoring NCT03508934?

NCT03508934 is sponsored by VA Office of Research and Development.

What drugs are being tested in NCT03508934?

Interventions in NCT03508934: GTS (Continuous Glucose Monitoring), POC (Point of Care).

What condition does NCT03508934 study?

NCT03508934 studies Diabetes Mellitus, Type 2, Hypoglycemia.

Is NCT03508934 still recruiting?

NCT03508934 is currently active, enrolled. Last updated 7 January 2026.

Last reviewed 2026-01-07 · How we verify

NCT03508934

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Continuous Glucose Monitoring Devices in Hospitalized Veterans With Diabetes

Active, enrolled NA Last updated 7 January 2026

What this trial tests

NA trial testing GTS (Continuous Glucose Monitoring) in Diabetes Mellitus, Type 2 in 218 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 July 2018

Primary endpoint
11 July 2025

30 April 2026

Quick facts

Lead sponsor	VA Office of Research and Development
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	218
Start date	1 July 2018
Primary completion	11 July 2025
Estimated completion	30 April 2026
Sites	1 location across United States

Drugs / interventions tested

GTS (Continuous Glucose Monitoring)
POC (Point of Care)

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Hypoglycemia — all drugs for Hypoglycemia →

Sponsor

VA Office of Research and Development — full company profile →

Who can join

21 and older, any sex, with Diabetes Mellitus, Type 2 or Hypoglycemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

More than 25% of the patients admitted in the general wards have a history of Diabetes Mellitus (DM). Up to 30% of the hospitalized diabetics develop hypoglycemia (low glucose values); a condition that is associated with seizures, cardiac arrhythmias, and even death. In Veterans, the prevalence is disproportionally higher. It is estimated that 40-50% of hospitalized Veterans are diabetics. In this clinical trial the investigators describe the development of a novel system, the Glucose Telemetry System (GTS), with which glucose values can be wirelessly transmitted from the patient's bedside to a monitor device at the nursing station. The goal of this work is to develop a more effective glucose surveillance system at the general wards, which can decrease hypoglycemia in the hospital and improve clinical outcomes.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System and Point-of-Care Capillary Glucose Testing in Hospitalized Patients With Type 2 Diabetes Treated With Basal-Bolus Insulin Regimen.
Galindo RJ, Migdal AL, Davis GM, Urrutia MA, et al · · 2020 · cited 130× · PMID 32641372 · DOI 10.2337/dc19-2073
Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline.
Galindo RJ, Umpierrez GE, Rushakoff RJ, Basu A, et al · · 2020 · cited 118× · PMID 32985262 · DOI 10.1177/1932296820954163
Reducing Inpatient Hypoglycemia in the General Wards Using Real-time Continuous Glucose Monitoring: The Glucose Telemetry System, a Randomized Clinical Trial.
Singh LG, Satyarengga M, Marcano I, Scott WH, et al · · 2020 · cited 118× · PMID 32759361 · DOI 10.2337/dc20-0840
Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic.
Galindo RJ, Aleppo G, Klonoff DC, Spanakis EK, et al · · 2020 · cited 107× · PMID 32536205 · DOI 10.1177/1932296820932903
Accuracy of Dexcom G6 Continuous Glucose Monitoring in Non-Critically Ill Hospitalized Patients With Diabetes.
Davis GM, Spanakis EK, Migdal AL, Singh LG, et al · · 2021 · cited 102× · PMID 34099515 · DOI 10.2337/dc20-2856
A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials.
Spanakis EK, Cook CB, Kulasa K, Aloi JA, et al · · 2023 · cited 47× · PMID 37592726 · DOI 10.1177/19322968231191104
Individualizing Inpatient Diabetes Management During the Coronavirus Disease 2019 Pandemic.
Pasquel FJ, Umpierrez GE. · · 2020 · cited 30× · PMID 32370606 · DOI 10.1177/1932296820923045
A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial.
Pasquel FJ, Lansang MC, Khowaja A, Urrutia MA, et al · · 2020 · cited 24× · PMID 32273271 · DOI 10.2337/dc19-1940

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Other VA Office of Research and Development trials

Trials by the same sponsor.

NCT07456150 — Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care · Phase 1 · not yet recruiting
NCT06746727 — The Development of a Transdiagnostic Intervention to Improve Social Functioning and Intimate Relationships Among Veteran · NA · not yet recruiting
NCT07362576 — Perinatal Peer Support for Veterans With Serious Mental Illness · NA · not yet recruiting
NCT06766331 — Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans · NA · not yet recruiting
NCT07397195 — ACT for Veterans With IBD and Mental Health Challenges · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03508934 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by VA Office of Research and Development
Last refreshed: 7 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03508934.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing